Annual/Quarterly Reports Summary
Beyond The Earnings: What The Latest SEC 10-Q Filing Reveals About Johnson Controls Inc (JCI) Future
January 30, 2024 JCI 0.88%
In 2023, the company focused on increasing vehicle production, capacity, and delivery capabilities, reducing costs, and improving and developing vehicle and battery technologies. They also aimed to vertically integrate and...
January 29, 2024 TSLA 9.80%
Netflix's revenue growth over the past three years has been driven by an increase in average paying memberships, although this has been partly offset by a decrease in average monthly...
January 26, 2024 NFLX 0.42%
CCL has experienced positive revenue growth over the past three years, with revenues reaching a record high of $21.6 billion. This growth is attributed to improvements in ticket prices,...
January 26, 2024 CCL -0.53%
Intel's financials have shown positive revenue growth over the past three years. The increase in revenue is primarily driven by higher demand for EyeQ products and Mobileye SuperVision systems. Operating...
January 26, 2024 INTC -6.70%
Schlumberger has experienced strong revenue growth in the past three years, with international sales being a major driver. The acquisition of Aker subsea business has also contributed to revenue growth....
January 24, 2024 SLB -1.17%
Over the past three years, the company has experienced positive revenue growth, primarily driven by higher pricing. However, this growth was partially offset by unfavorable foreign exchange and a decrease...
January 23, 2024 PG 0.93%
Adobe experienced strong demand in fiscal year 2023 for its Digital Media and Digital Experience offerings, driven by its innovative product roadmap. ADBE saw growth in software-based subscription revenue...
January 17, 2024 ADBE 1.89%
Nike has seen positive revenue growth over the past three years, driven by store sales growth and the addition of new stores. Footwear revenues increased 1%, while Apparel revenues decreased...
January 5, 2024 NKE -1.47%
Walgreens Boots Alliance reported a 6.4% increase in revenue for the three months ended November 30, 2023, driven by higher branded drug inflation, strong execution in pharmacy services, and cost...
January 4, 2024 WBA -0.18%